Supporting and Communicating About Advanced Breast Cancer Treatments
Core 3: Communications, Administrations, Advocacy, and Project Management
This project helps manage and communicate about an important breast cancer treatment program that aims to find better ways to treat patients.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-11125952 on NIH RePORTER |
What this research studies
This core provides essential support for the I-SPY2.2 breast cancer treatment program, which explores new ways to optimize patient outcomes. It manages communications, administration, and project coordination to ensure all parts of the program work together smoothly. A key focus is integrating patient advocacy into all aspects, making sure patient perspectives are heard and understood. This core also helps ensure the program meets all regulatory requirements and collaborates effectively with the study sponsor and clinical teams.
Who could benefit from this research
Good fit: Patients with breast cancer who might be eligible for participation in the I-SPY2.2 clinical trial could potentially benefit from the advancements this program supports.
Not a fit: Patients not diagnosed with breast cancer or those who do not meet the specific criteria for the I-SPY2.2 trial would not directly benefit from this program.
Why it matters
Potential benefit: If successful, this core's work helps ensure the I-SPY2.2 program can efficiently discover and implement new, optimized breast cancer treatment strategies for patients.
How similar studies have performed: The I-SPY2 trial, which this program builds upon, has a strong track record of successfully identifying promising new breast cancer treatments.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Esserman, Laura J — University of California, San Francisco
- Study coordinator: Esserman, Laura J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.